These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 34239333

  • 21. Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis.
    Raterman HG, Bultink IEM, Lems WF.
    Drugs; 2019 Jul; 79(10):1065-1087. PubMed ID: 31201710
    [Abstract] [Full Text] [Related]

  • 22. [Glucocorticoid and Bone. Efficacy and safety of bisphosphonate in treatment of glucocorticoid induced osteoporosis].
    Tanaka I.
    Clin Calcium; 2014 Sep; 24(9):1371-8. PubMed ID: 25177010
    [Abstract] [Full Text] [Related]

  • 23. Denosumab in the treatment of glucocorticoid-induced osteoporosis.
    Coskun Benlidayi I.
    Rheumatol Int; 2018 Nov; 38(11):1975-1984. PubMed ID: 30019224
    [Abstract] [Full Text] [Related]

  • 24. Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.
    Rossini M, Orsolini G, Viapiana O, Adami S, Gatti D.
    Endocrine; 2015 Aug; 49(3):620-7. PubMed ID: 25649760
    [Abstract] [Full Text] [Related]

  • 25. Glucocorticoid-induced osteoporosis: an update.
    Compston J.
    Endocrine; 2018 Jul; 61(1):7-16. PubMed ID: 29691807
    [Abstract] [Full Text] [Related]

  • 26. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM, Valeriano J, Vasey FB, Carter JD.
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses.
    Amiche MA, Lévesque LE, Gomes T, Adachi JD, Cadarette SM.
    J Bone Miner Res; 2018 Mar; 33(3):419-429. PubMed ID: 29068496
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. An update on glucocorticoid-induced osteoporosis.
    Lane NE.
    Rheum Dis Clin North Am; 2001 Feb; 27(1):235-53. PubMed ID: 11285998
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Glucocorticoid-induced osteoporosis: mechanisms for bone loss; evaluation of strategies for prevention.
    Mitchell DR, Lyles KW.
    J Gerontol; 1990 Sep; 45(5):M153-8. PubMed ID: 2203846
    [Abstract] [Full Text] [Related]

  • 33. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA, Hamdy NA.
    Scand J Gastroenterol Suppl; 2006 Sep; (243):59-64. PubMed ID: 16782623
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.
    Kenanidis E, Potoupnis ME, Kakoulidis P, Leonidou A, Sakellariou GT, Sayegh FE, Tsiridis E.
    Expert Opin Drug Saf; 2015 Jul; 14(7):1035-53. PubMed ID: 25952267
    [Abstract] [Full Text] [Related]

  • 36. [Glucocorticoid induced osteoporosis].
    Anić B, Mayer M.
    Reumatizam; 2014 Jul; 61(2):105-12. PubMed ID: 25427404
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Glucocorticoid osteoporosis.
    Sambrook PN.
    Curr Pharm Des; 2002 Jul; 8(21):1877-83. PubMed ID: 12171526
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.